Microsoft word - publikationen.doc

Publikationen - Auswahl der letzten 5 Jahre
Peginterferon alfa-2a/ribavirin for 48 or 72 weeks in hepatitis C genotypes 1 and 4 patients
with slow virologic response.
Ferenci P, Laferl H, Scherzer TM, Maieron A, Hofer H, Stauber R, Gschwantler M, Brunner H, Wenisch C, Bischof M, Strasser M, Datz C, Vogel W, Löschenberger K, Steindl-Munda P; Gastroenterology. 2010 Feb;138(2):503-12, 512.e1. Epub 2009 Nov 10 Germline mutation of the E-cadherin gene in three sibling cases with advanced gastric
cancer: clinical consequences for the other family members.
Mayrbaeurl B, Keller G, Schauer W, Burgstaller S, Czompo M, Hoebling W, Knoflach P, Duba HC, Eur J Gastroenterol Hepatol. 2010 Mar;22(3):306-10. Adalimumab for the treatment of Crohn's disease - consensus paper of the Working Group
"chronic inflammatory bowel diseases" of the Austrian Society for Gastroenterology and
Hepatology
Reinisch W, Haas T, Kaser A, Petritsch W, Vogelsang H, Feichtenschlager T, Novacek G, Siebert Z Gastroenterol. 2009 Apr;47(4):372-80. Epub 2009 Apr 8. German. Quantitative autonomic testing in the management of botulism.
Topakian R, Heibl C, Stieglbauer K, Dreer B, Nagl M, Knoflach P, Aichner FT. J Neurol. 2009 May;256(5):803-9. Epub 2009 Feb 25. Concomitant manifestation of pyoderma gangrenosum and colorectal carcinoma.
Bunte C, Popp-Habeler J, Mischer P, Tuppy H, Haidenthaler A, Knoflach P, Kirchgatterer A. Scand J Gastroenterol. 2008;43(6):756-8. Peginterferon alfa-2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with
rapid virological response.
Ferenci P, Laferl H, Scherzer TM, Gschwantler M, Maieron A, Brunner H, Stauber R, Bischof M, Bauer B, Datz C, Löschenberger K, Formann E, Staufer K, Steindl-Munda P; Austrian Hepatitis Gastroenterology. 2008 Aug;135(2):451-8. Epub 2008 May 27. The frequency of wound infections after PEG-placement and utilization of glycogel wound
dressing: a randomized controlled trial
Aschl G, Kirchgatterer A, Fleischer M, Hinterreiter M, Hubner D, Kranewitter W, Stadler B, Wien Klin Wochenschr. 2008;120(7-8):224-7. German A randomized, prospective trial of ribavirin 400 mg/day versus 800 mg/day in combination
with peginterferon alfa-2a in hepatitis C virus genotypes 2 and 3.
Ferenci P, Brunner H, Laferl H, Scherzer TM, Maieron A, Strasser M, Fischer G, Hofer H, Bischof M, Stauber R, Gschwantler M, Steindl-Munda P, Staufer K, Löschenberger K; Austrian Hepatitis Variceal hemorrhage in a patient with ulcerative colitis treated with 6-Thioguanine.
Inflamm Bowel Dis. 2008 Apr;14(4):582-3. A systematic survey evaluating 6-thioguanine-related hepatotoxicity in patients with
inflammatory bowel disease.
Teml A, Schwab M, Hommes DW, Almer S, Lukas M, Feichtenschlager T, Florin T, Seiderer J, Petritsch W, Bokemeyer B, Kreisel W, Herrlinger KR, Knoflach P, Bonaz B, Klugmann T, Herfarth Wien Klin Wochenschr. 2007;119(17-18):519-26. Use of infliximab in ulcerative colitis
Tilg H, Feichtenschlager T, Knoflach P, Petritsch W, Schöfl R, Vogelsang H, Reinisch W. Z Gastroenterol. 2007 Aug;45(8):907-11. German Long-term outcome following placement of percutaneous endoscopic gastrostomy in
younger and older patients.
Kirchgatterer A, Bunte C, Aschl G, Fritz E, Hubner D, Kranewitter W, Fleischer M, Hinterreiter M, Scand J Gastroenterol. 2007 Feb;42(2):271-6. ERCP is safe and effective in patients 80 years of age and older compared with younger
patients.
Fritz E, Kirchgatterer A, Hubner D, Aschl G, Hinterreiter M, Stadler B, Knoflach P. Gastrointest Endosc. 2006 Dec;64(6):899-905. Endoscopy in IBD. A Consensus Report of the IBD Working of the Austrian Association of
Gastroenterology and Hepatology
Petritsch W, Tillinger W, Vogelsang H, Reinisch W, Knoflach P, Tilg H. Z Gastroenterol. 2006 Nov;44(11):1183-92. German Aminosalicylates and steroids in the treatment ot chronic inflammatory bowel diseases--
consensus paper of the Working Group for Chronic Inflammatory Bowel Diseases of the
Dejaco C, Haas T, Kirchgatterer A, Miehsler W, Wenzl H, Knoflach P, Petritsch W, Vogelsang H, Z Gastroenterol. 2006 Jun;44(6):525-38; discussion 539. Review. German. 6-Thioguanine treatment in inflammatory bowel disease: a critical appraisal by a European
6-TG working party.
de Boer NK, Reinisch W, Teml A, van Bodegraven AA, Schwab M, Lukas M, Ochsenkühn T, Petritsch W, Knoflach P, Almer S, van der Merwe SW, Herrlinger KR, Seiderer J, Vogelsang H, Digestion. 2006;73(1):25-31. Epub 2006 Feb 21. Review. Weight loss, abdominal pain and anemia after a holiday abroad--case report of lead
poisoning
Dtsch Med Wochenschr. 2005 Oct 7;130(40):2253-6. German. Lansoprazole-associated collagenous colitis: a case report.
Rammer M, Kirchgatterer A, Höbling W, Knoflach P.

Source: http://www.klinikum-wegr.at/klinikum/resource/582127231698182011_640602255847919221_1DOck7bI.pdf

Microsoft word - ccx frx press release final _4_.doc

Contacts: Forest Laboratories, Inc. ChemoCentryx, Inc. For media inquiries Partners Karen L. Bergman 650.575.1509 or Michelle Corral 415.794.8662 CHEMOCENTRYX AND FOREST LABORATORIES TO COLLABORATE ON THE DEVELOPMENT AND COMMERCIALIZATION OF NOVEL ORAL RHEUMATOID ARTHRITIS AND MULTIPLE SCLEROSIS THERAPEUTICS March 15, 2004; San Carlos, CA and New York, NY

The co-evolution of people, plants, and parasites: biological and cultural adaptations to malaria*

3URFHHGLQJV RI WKH 1XWULWLRQ 6RFLHW\    ± XWULWLRQ 6RFLHW\  ‹ 1XWULWLRQ 6RFLHW\  7KH 6XPPHU 0HHWLQJ RI WKH 1XWULWLRQ 6RFLHW\ ZDV KHOG DW WKH 8QLYHUVLW\ RI /HHGV RQ ± -XO\ 7KH FRHYROXWLRQ RI SHRSOH SODQWV DQG SDUDVLWHV ELRORJLFDO DQG FXOWXUDO'HSDUWPHQW RI $QWKURSRORJ\ DQG 'LYLVLRQ RI +HDOWK (FRORJ\ 6FKRRO RI 0HGLFLQH  8QLYHUVLW\ RI +DZDLL3U

Copyright © 2018 Medical Abstracts